| Imaging CAR T-cell kinetics in solid tumors: Translational implications MS Skovgard, HR Hocine, JK Saini, M Moroz, RY Bellis, S Banerjee, ... Molecular Therapy-Oncolytics 22, 355-367, 2021 | 23 | 2021 |
| CAR T-cell therapy for pleural mesothelioma: Rationale, preclinical development, and clinical trials NK Chintala, D Restle, H Quach, J Saini, R Bellis, M Offin, J Beattie, ... Lung Cancer 157, 48-59, 2021 | 16 | 2021 |
| Abstract LB-378: Regional delivery of clinical-grade mesothelin-targeted CAR T cells with cell-intrinsic PD-1 checkpoint blockade: Translation to a phase I trial S Kiesgen, C Linot, HT Quach, J Saini, R Bellis, S Banerjee, Z Hou, ... Cancer Research 80 (16_Supplement), LB-378-LB-378, 2020 | 9 | 2020 |
| Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma NK Chintala, JK Choe, E McGee, R Bellis, JK Saini, S Banerjee, ... Frontiers in Immunology 14, 1112960, 2023 | 6 | 2023 |
| Tumor-Targeted Nonablative Radiation Promotes Solid Tumor CAR T-cell Therapy Efficacy HT Quach, MS Skovgard, J Villena-Vargas, RY Bellis, NK Chintala, ... Cancer Immunology Research 11 (10), 1314-1331, 2023 | 3 | 2023 |
| Next-generation immunotherapy for solid tumors: combination immunotherapy with crosstalk blockade of TGFβ and PD-1/PD-L1 HT Quach, Z Hou, RY Bellis, JK Saini, A Amador-Molina, PS Adusumilli, ... Expert opinion on investigational drugs 31 (11), 1187-1202, 2022 | 1 | 2022 |
| 46MO Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor PS Adusumilli, AM Amador, N Chintala, Z Hou, M Offin, J Pineda, ... Annals of Oncology 32, S1392-S1393, 2021 | 1 | 2021 |
| DLL3-targeted CAR T-cell therapy in pre-clinical models for small cell lung cancer: safety, efficacy, and challenges RY Bellis, PS Adusumilli, A Amador-Molina Translational Lung Cancer Research 13 (3), 694, 2024 | | 2024 |
| Immunotherapy using CAR T: What we have learned from trials and where we are heading A Zhu, R Bellis, J Saini, C Fong, PS Adusumilli NK Cells in Cancer Immunotherapy: Successes and Challenges, 369-384, 2023 | | 2023 |
